Back

Lp(a): Is there any benefit from reducing it?

26 August 2018 (08:52 - 09:15)
Organised by:
Congress Presentation Part of: Lipid-lowering therapy beyond LDL Cholesterol Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Triglyceride-rich lipoproteins in secondary prevention: do we need to treat?
Professor J. Chapman (Paris, FR)
Slides Video
Presentation thumbnail
Is it time to sing the requiem for HDL cholesterol?
Professor U. Laufs (Leipzig, DE)
Slides Video
Presentation thumbnail
Does LDL induce inflammation? If so, does it matter?
Professor J. Jukema (Leiden, NL)
Slides Video

Access the full session

Session thumbnail
Lipid-lowering therapy beyond LDL Cholesterol

The Event

Event poster

ESC Congress 2018

26 August 2018 08:52 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
28 August 2020
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025
thumbnail
Congress Presentation
EAS Consensus on Lp(a) 2022- What to measure, in whom to measure, how to interpret and what to do - Q&A .
29 August 2022
thumbnail
Congress Presentation
Extension of coronary artery disease and resistance to lipid-lowering treatment. Value of Lp(a)
23 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources